NR5A2 and invasive breast carcinoma: NR5A2 (or LRH1) is a zinc finger transcription factor which can regulate CDKN1A expression in BrCa [70], and has been positively associated with BrCa proliferation [71], drug resistance [72], aggressiveness [73], high grade, and poor outcome [74].